Skip to main content
SpringerLink
Log in

The fifteenth International Conference on Progress in Vaccination against Cancer (PIVAC-15), 6–8 October 2015, Tübingen, Germany: looking back on 15 years of progress

  • Meeting Report
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

AML:

Acute myeloid leukaemia

mDC:

Myeloid dendritic cell

MICA/B:

MHC class I polypeptide-related sequence A/B

Nrf2:

Nuclear factor (erythroid-derived 2)-like 2

pDC:

Plasmacytoid dendritic cell

Th1:

T helper cell type 1

Treg:

Regulatory T cell

Acknowledgments

We thank the following companies and organisations for sponsoring the meeting: CTL Europe, CureVac, Immatics, Springer Nature, European Federation of Immunological Societies (EFIS), Autoimmun Diagnostika (AID), Becton Dickinson (BD), CellGenix, JPT Peptide Technologies, Pantec Biosolutions, Faculty of 1000 and the European Association for Cancer Research (EACR). We are especially grateful to Kathryn Wass and Laura Strachan of the EACR for their outstanding work in organising the meeting, without which it would not have been the resounding success that it was. We also gratefully acknowledge Alexander Martens, Lisa Speigl, Kilian Wistuba-Hamprecht and Nicole Janssen for their assistance in the preparation of this report.

Author information

Authors and Affiliations

  1. Department of Internal Medicine II, University Hospital Tübingen, Waldhörnlestr. 22, 72072, Tübingen, Germany

    Christopher Shipp & Graham Pawelec

Authors
  1. Christopher Shipp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Graham Pawelec
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher Shipp.

Ethics declarations

The authors declare that they have no conflict of interest. Graham Pawelec is chair of the PIVAC scientific organising committee.

Additional information

This meeting report is a summary of presentations from the Fifteenth International Conference on Progress in Vaccination against Cancer, PIVAC 15, published together with a series of Focussed Research Reviews based on lectures given at the conference.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shipp, C., Pawelec, G. The fifteenth International Conference on Progress in Vaccination against Cancer (PIVAC-15), 6–8 October 2015, Tübingen, Germany: looking back on 15 years of progress. Cancer Immunol Immunother 66, 273–279 (2017). https://doi.org/10.1007/s00262-016-1888-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-016-1888-4

Keywords

Search

Navigation